MR biomarkers in imaging DMD clinical trial network

被引：0

作者：

Forbes, S. ^{[1
]}

Willcocks, R. ^{[1
]}

Triplett, W. ^{[1
]}

Arora, H. ^{[1
]}

Rooney, W. ^{[2
]}

Wang, D. ^{[3
]}

Daniels, M. ^{[1
]}

Finanger, E. ^{[2
]}

Finkel, R. ^{[4
]}

Tennekoon, G. ^{[3
]}

Sweeney, H. ^{[1
]}

Walter, G. ^{[1
]}

Vandenborne, K. ^{[1
]}

机构：

[1] Univ Florida, Gainesville, FL USA

[2] OHSU, Portland, OR USA

[3] CHOP, Philadelphia, PA USA

[4] Nemours, Orlando, FL USA

来源：

NEUROMUSCULAR DISORDERS | 2018年 / 28卷

关键词：

D O I：

10.1016/j.nmd.2018.06.062

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

P.34

引用

页码：S41 / S41

页数：1

共 50 条

[41] Clinical Trial Design and Development Work Group Within the Quantitative Imaging Network
Jones, Ella F.
Buatti, John M.
Shu, Hui-Kuo
Wahl, Richard L.
Kurland, Brenda F.
Linden, Hannah M.
Mankoff, David A.
Rubin, Daniel L.
Tata, Darrell
Nordstrom, Robert J.
Hadjiyski, Lubomir
Holdhoff, Matthias
Schwartz, Lawrence H.
TOMOGRAPHY, 2020, 6 (02) : 60 - 64
[42] Pentoxifylline as a rescue treatment for DMD A randomized double-blind clinical trial
Escolar, D. M.
Zimmerman, A.
Bertorini, T.
Clemens, P. R.
Connolly, A. M.
Mesa, L.
Gorni, K.
Kornberg, A.
Kolski, H.
Kuntz, N.
Nevo, Y.
Tesi-Rocha, C.
Nagaraju, K.
Rayavarapu, S.
Hache, L. P.
Mayhew, J. E.
Florence, J.
Hu, F.
Arrieta, A.
Henricson, E.
Leshner, R. T.
Mah, J. K.
NEUROLOGY, 2012, 78 (12) : 904 - 913
[43] Imaging Biomarkers for Adult Medulloblastomas: Genetic Entities May Be Identified by Their MR Imaging Radiophenotype
Keil, V. C.
Warmuth-Metz, M.
Reh, C.
Enkirch, S. J.
Reinert, C.
Beier, D.
Jones, D. T. W.
Pietsch, T.
Schild, H. H.
Hattingen, E.
Hau, P.
AMERICAN JOURNAL OF NEURORADIOLOGY, 2017, 38 (10) : 1892 - 1898
[44] Will it be possible to do a phase 2 clinical trial of myoblast transplantation for DMD patients?
Tremblay, J. P.
Skuk, D.
NEUROMUSCULAR DISORDERS, 2009, 19 (8-9) : 635 - 635
[45] DMD HUB: Expanding clinical trial capacity for Duchenne muscular dystrophy in the UK
Heslop, E.
Straub, V.
Guglieri, M.
Turner, C.
Davis, B.
Crossley, E.
Johnson, A.
Bushby, K.
NEUROMUSCULAR DISORDERS, 2017, 27 : S100 - S100
[46] DMD HUB: expanding clinical trial capacity for Duchenne muscular dystrophy in the UK
Heslop, E.
Guglieri, M.
Bushby, K.
Turner, C.
Davis, B.
Litchfield, N.
Crossley, E.
Johnson, A.
Straub, V.
NEUROMUSCULAR DISORDERS, 2018, 28 : S38 - S38
[47] MR Imaging in the Evaluation of Equivocal Clinical and Imaging Findings of the Breast
Leung, Jessica W. T.
MAGNETIC RESONANCE IMAGING CLINICS OF NORTH AMERICA, 2010, 18 (02) : 295 - +
[48] Reduction of anxiety during MR imaging: a controlled trial
Grey, SJ
Price, G
Mathews, A
MAGNETIC RESONANCE IMAGING, 2000, 18 (03) : 351 - 355
[49] Clinical trial designs for prospective validation of biomarkers
Mandrekar, SJ
Grothey, A
Goetz, MP
Sargent, DJ
AMERICAN JOURNAL OF PHARMACOGENOMICS, 2005, 5 (05) : 317 - 325
[50] Biomarkers, Subgroup Evaluation, and Clinical Trial Design
Baker, Stuart G.
Kramer, Barnett S.
Sargent, Daniel J.
Bonetti, Marco
DISCOVERY MEDICINE, 2012, 13 (70) : 187 - U71

← 1 2 3 4 5 →